| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Clinical Chemistry, Institute of Medical and Veterinary Science (B.E.C., A.G.N., H.A.M.) Adelaide, South Australia
The Department of Pathology (B.E.C.), University of Adelaide Adelaide, South Australia
The Departments of Nuclear Medicine (B.E.C.) and Medicine (M.H.), Royal Adelaide Hospital Adelaide, South Australia
Address all correspondence and requests for reprints to: Prof. B. E. C. Nordin, Division of Clinical Chemistry, Institute of Medical and Veterinary Science, Frome Road, Adelaide 5000, South Australia.
We have estimated the relative contributions of age and menopause to forearm mineral density in 485 normal postmenopausal women up to age 75 yr. In 87 pairs matched for years since menopause, in which 1 member was below 61 yr and the other was 61 yr or older, the mean bone density was significantly lower in the older than in the younger subjects despite their identical years since menopause (P < 0.001). Further analysis suggested a model for bone loss after the menopause which comprises a menopausal component of exponential type and an age-related component which is linear and starts in the mid-50s. According to this model, a 70-yr-old woman has lost 11% of her bone due to menopause and 18% as a function of age. Thereafter, the age-related function is dominant. Early menopause is associated with a self-limiting loss of bone which does not progress further until aging exerts its effect. The main conclusion is that the significance of early menopause as a risk factor for osteoporosis has been overstated.
Received December 28, 1988.
This article has been cited by other articles:
![]() |
D J Hadjidakis, A M Mylonakis, M E Sfakianakis, A E Raptis, and S A Raptis Diabetes and premature menopause: is their co-existence detrimental to the skeleton? Eur. J. Endocrinol., March 1, 2005; 152(3): 437 - 442. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Okada, S. Nomura, Y. Ikoma, E. Yamamoto, T. Ito, T. Mitsui, K. Tamakoshi, and S. Mizutani Effects of Postmenopausal Hormone Replacement Therapy on HbA1c Levels Diabetes Care, April 1, 2003; 26(4): 1088 - 1092. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Saika, D. Inoue, S. Kido, and T. Matsumoto 17{beta}-Estradiol Stimulates Expression of Osteoprotegerin by a Mouse Stromal Cell Line, ST-2, via Estrogen Receptor-{{alpha}} Endocrinology, June 1, 2001; 142(6): 2205 - 2212. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Orwoll and H. D. Nelson Does Estrogen Adequately Protect Postmenopausal Women Against Osteoporosis: An Iconoclastic Perspective J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 1872 - 1874. [Full Text] |
||||
![]() |
J. G. H. Sterck, J. Klein-Nulend, P. Lips, and E. H. Burger Response of normal and osteoporotic human bone cells to mechanical stress in vitro Am J Physiol Endocrinol Metab, June 1, 1998; 274(6): E1113 - E1120. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. Felson, Y. Zhang, M. T. Hannan, D. P. Kiel, P. Wilson, and J. J. Anderson The Effect of Postmenopausal Estrogen Therapy on Bone Density in Elderly Women N. Engl. J. Med., October 14, 1993; 329(16): 1141 - 1146. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |